Article
PCSK5M452I Is a Recessive Hypomorph Exclusive to MCF10DCIS.com Cells.
Molecular cancer research : MCR - 6 Feb 2026
Marohl Taylor, Atkins Kristen A, Wang Lixin, Janes Kevin A
Abstract excerpt
The most widely used cell line for studying ductal carcinoma in situ (DCIS) premalignancy is the transformed breast epithelial cell line, MCF10DCIS.com. During its original clonal isolation and selection, MCF10DCIS.com acquired a heterozygous M452I mutation in the proprotein convertase PCSK5, which has never been reported in any human cancer. The mutation is noteworthy because PCSK5 matures GDF11, a TGFβ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
